Delivery Order SPE2DB22D3501-SPE2DB23FWP17
Award Date 7/25/23
Potential Completion Date 8/15/23
Potential Value $3.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $15,227 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. As the prime contractor, Amerisourcebergen will supply the implants to the Defense Logistics Agency from its facility in Conshohocken, Pennsylvania. The delivery order was issued against an existing DLA contract vehicle and has a period of performance from June 22, 2023 through July 14, 2023. No set aside designation or subcontractors were identified....
- The Defense Logistics Agency awarded a delivery order valued at $4,334.59 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This non-set-aside, firm fixed-price delivery order was competitively awarded on December 11, 2025, with an ultimate completion date of January 5, 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,789.25 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of October 9, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the procurement was open to all qualified vendors. This delivery order is...
- The Defense Logistics Agency awarded a $5,075.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. The delivery order was issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding on July 21, 2023. The delivery order provides a specified quantity of the Zoladex implant to...
- The Defense Logistics Agency awarded a $11,757.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes, with an ultimate completion date of November 10, 2025. This non-set-aside contract was competitively awarded on October 20, 2025, with performance to be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency Troop Support Medical awarded a $10,152 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of Zoladex 10.8 mg implant syringes. The place of performance is Conshohocken, Pennsylvania. The contract period runs from July 25, 2023 through August 15, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a contract ceiling value of $37,190. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive award. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,859.50 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes, with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a $6,055.80 delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Zoladex 10.8 mg implant syringes, with final delivery required by January 29, 2026. This contract utilizes a firm fixed-price structure with no set-aside designation, reflecting a competitive award to the prime contractor. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Zoladex 10.8 mg implant syringes with a ceiling value of $23,515.44. This firm fixed-price delivery order, set to be completed by January 14, 2026, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis, reflecting AmerisourceBergen's capability to meet federal procurement standards through...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWP17Delivery Order
The Defense Logistics Agency awarded a $3,383.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. The implants will be provided under contract number 4561617893 and delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 15, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supplies medical materials to support the military health system. This delivery order for Zoladex, a drug used to treat prostate cancer, will help the Defense Logistics Agency maintain critical medical supplies for DOD medical facilities.
Generated 12/22/23, 9:35 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 7/25/23 |